Amid rising concerns about benzodiazepines, some patients who try to quit are suffering extreme anxiety, memory loss and ...
In a trial, sotagliflozin use in patients with diabetes and chronic kidney disease (CKD) was associated with lower risk of ischemic cardiovascular outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback